Sep 22, 2025 09:15AM
Sep 22, 2025 09:15AM
Sep 9, 2025 08:15AM
Sep 9, 2025 08:15AM
Sep 8, 2025 08:45AM
Sep 8, 2025 08:45AM
Sep 8, 2025 08:45AM CERo Therapeutics Announces Dose Intensification in Phase 1 Study of CER-1236 in Acute Myeloid Leukemia
Sep 8, 2025 08:45AM
Sep 5, 2025 08:00AM
Sep 5, 2025 08:00AM
Jun 17, 2025 08:15AM
Jun 17, 2025 08:15AM
Jun 6, 2025 08:15AM
Jun 6, 2025 08:15AM CERo Therapeutics, Inc. Announces Option Exercise for Additional Series D Financing
Apr 22, 2025 08:15AM
Apr 22, 2025 08:15AM
Mar 31, 2025 08:15AM
Mar 31, 2025 08:15AM
Mar 27, 2025 08:15AM
Mar 27, 2025 08:15AM
Feb 6, 2025 08:15AM CERo Therapeutics (CERO) Highlights Progress
Feb 6, 2025 08:15AM
Feb 6, 2025 08:15AM
Nov 15, 2024 08:45AM
Nov 15, 2024 08:45AM
Oct 21, 2024 09:00AM
Oct 21, 2024 09:00AM
Oct 2, 2024 09:15AM CERo Therapeutics (CERO) Appoints Al Kucharchuk as CFO, Kristen Pierce as Chief Development Officer
Oct 2, 2024 09:15AM
Sep 25, 2024 09:19AM
Sep 25, 2024 09:17AM
Jul 8, 2024 08:00AM
Jul 8, 2024 08:00AM
Jun 13, 2024 08:23AM
Jun 13, 2024 08:15AM CERo Therapeutics, Inc. Completes IND-Enabling Activities Following Successful Manufacturing Runs for Lead Compound CER-1236
Jun 6, 2024 08:00AM
May 15, 2024 08:02AM
May 15, 2024 08:00AM

312,667 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All